Bavarian Nordic A/S (CPH:BAVA)
Denmark · Delayed Price · Currency is DKK 208.20
+0.80 (0.39%)
Sep 18, 2026, 4:59 PM CET
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of 15.76 billion as of September 18, 2026. Its market cap has decreased by -13.09% in one year.
Market Cap
15.76B
Enterprise Value
13.54B
Revenue
6.34B
Ranking
n/a
PE Ratio
10.72
Stock Price
208.20
ChartMarket Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 42.71M to 15.76B, an increase of 36,803.07%. That is a compound annual growth rate of 23.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 15.76B | 5.52% |
| Dec 30, 2025 | 14.94B | 0.41% |
| Dec 30, 2024 | 14.88B | 7.57% |
| Dec 29, 2023 | 13.83B | -8.19% |
| Dec 30, 2022 | 15.06B | -20.32% |
| Dec 30, 2021 | 18.90B | 73.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.24T |
| Genmab | 132.12B |
| Coloplast | 94.44B |
| Demant | 63.10B |
| ALK-Abelló | 44.15B |
| H. Lundbeck | 41.63B |
| Zealand Pharma | 18.59B |
| Ambu A/S | 17.10B |